ESC 365 - Doctor Kaspar Broch

Speaker illustration

Doctor Kaspar Broch

Oslo University Hospital Rikshospitalet, Oslo (Norway)

Member of:

Evolocumab for cardiac allograft vasculopathy

Event: ESC Congress 2023

Topic: Heart Transplantation

Session: New trials miscellany

Design of the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)

Event: Heart Failure 2023

Topic: Heart Transplantation

Session: Chronic heart failure - treatment 2

Soluble ST2 is strongly associated with outcomes in pulmonary arterial hypertension

Event: Heart Failure 2023

Topic: Pulmonary Hypertension

Session: Pulmonary circulation

Prevalence and prognostic implication of iron deficiency in patients with severe aortic stenosis

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease – Epidemiology, Prognosis, Outcome

Right ventricular improvement parallels left ventricular improvement after introduction of therapy for dilated cardiomyopathy

Event: HEART FAILURE 2016

Topic: Right ventricular function

Session: Right ventricular function

Echocardiography predicts right ventricular size and function in patients with dilated cardiomyopathy: a comparison with magnetic resonance imaging

Event: HEART FAILURE 2016

Topic: Right ventricular function

Session: Right ventricular function

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources